Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Phase I/II Study of Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia
NCT04258943Phase 2Active, not recruiting
- Sponsor
- Children's Oncology Group
- Start
- Jul 2020
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by Children's Oncology Group. Started Jul 2020; status: active, not recruiting.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT04258943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04258943.